Two legislative committees in Missouri have voted “Yes” on a measure that would require a study on the efficacy of using alternative medicines and therapies including, but not limited to MDMA psilocybin, and ketamine.
Missouri House Bill 1154 was passed on March 7 by the Veterans Committee in a unanimous vote (11 to 0), and on Monday it was given approval by the Administrative Oversight Committee. The vote Monday was also unanimous, 10 to 0.
Filed by Representative Dan Houx, this bill “requires the Department of Health and Senior Services, in
collaboration with a Missouri university hospital and medical center operated by the Department of Veterans Affairs in Missouri, to conduct a study on the efficacy of using alternative medicines and therapies, including, but not limited to, the use of MDMA, psilocybin, and ketamine for the treatment of patients suffering from post-traumatic stress disorder, treatment-resistant depression, substance abuse disorders, or who require end-of-life care.”